Infusion Pumps Market (2025-2032)

Infusion pumps enable healthcare providers to provide easy and seamless delivery of fluids into the patient’s body without frequently being in contact with them. These solutions help healthcare professionals streamline patient medications in a controlled way, reducing the chances of errors or overdose. Moreover, advanced infusion pumps give patients the accessibility to carry out their daily tasks with ease while being on medications. Additionally, the COVID-19 pandemic triggered several end users' adoption of infusion pumps, such as hospitals, clinics, and ambulatory centers, due to their ability to provide medications to patients without contact with them.

The growth of this market is driven by the increasing demand and adoption of patient engagement solutions, efforts to enhance patient-centric care by end users, growing industry consolidation through partnerships and collaborations, government initiatives and regulatory upgradation, rising healthcare expenditure, and rising prevalence of chronic diseases coupled with the increasing geriatric population. However, patient data privacy and safety concerns may restrain the growth of this market.

Furthermore, the growing adoption of wearable and mobile-based digital healthcare solutions and emerging economies are expected to offer significant growth opportunities for players in this market. However, the lack of digital literacy, the high cost associated with deploying healthcare IT solutions, and the lack of skilled IT personnel in the healthcare industry are challenging the growth of infusion pump market.

The prevalence of chronic diseases and conditions such as cancer, diabetes, and heart disease is rising globally. According to the WHO, 41 million people die from chronic diseases each year, accounting for around 74% of all deaths globally. Growth in the geriatric population and social behaviors such as tobacco and alcohol use, physical inactivity, and unhealthy diets are major factors driving a steady increase in the number of people suffering from chronic diseases. According to the International Diabetes Federation, the global prevalence of diabetes is estimated to increase from 10.5% of the global population in 2021 to 11.3% in 2032.

Also, chronic diseases are often associated with the elderly population due to the declining bodily functions and immunity among this population segment. Aging is associated with progressive deterioration in the structure and functioning of organs. The elderly population is more prone to various chronic diseases. According to World Population Prospects, the population aged 65 and above is growing more rapidly than other age groups.

In 2019, 703 million people were in the age group of 65 years and above globally. This number is projected to reach 1.5 billion by 2050. This remarkable growth in the elderly population is driven by declining fertility rates and improvements in longevity. Infusion pumps are commonly used to manage diabetes, particularly for individuals with type 1 diabetes. Insulin pumps deliver a continuous supply of insulin, mimicking the function of the pancreas. This helps regulate blood sugar levels and allows for flexibility in insulin dosing. Insulin pump can also be programmed to deliver bolus doses before meals.

Furthermore, non-communicable diseases (NCDs), such as cancer, cardiovascular disease, diabetes, and mental illness, are becoming more prevalent. NCDs currently account for 70% of all deaths globally, with the majority recorded in low- & middle-income countries. The International Agency for Research on Cancer (IARC) estimates that globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women lose their lives. As per WHO estimates, the global prevalence of new cancer cases is expected to increase from 19.2 million in 2020 to 24.5 in 2032, while the global mortality from cancer is expected to increase from 9.9 million in 2020 to 12.9 million in 2032. Many cancer patients receive chemotherapy and other medications through infusion pumps. These pumps provide a steady and controlled infusion of chemotherapy drugs, reducing the risk of side effects and ensuring the patient receives the prescribed treatment regimen.

The overall scenario indicates that the rising prevalence of chronic diseases, coupled with the increasing geriatric population, is expected to increase the patient pool demanding highly innovative solutions during their diagnosis journey, further driving the growth of the infusion pumps market. Infusion pumps offer several advantages in managing chronic diseases, including precise dosing, reduced risk of human error, and the ability to customize infusion rates and schedules based on individual patient needs.